OverT Bio Overview
- Year Founded
-
2022

- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$120K
- Investors
-
11
OverT Bio General Information
Description
Operator of a biotech company intended to provide cell therapy for cancers. The company's cell therapies identify and develop novel genetic modifications that help immune cells overcome barriers created by tumors and lead to effective and durable immunotherapies, enabling the healthcare industry to identify and cure cancer.
Contact Information
Website
www.overt.bioCorporate Office
- 430 East 29th Street
- 14 floor
- New York, NY 10016
- United States
Corporate Office
- 430 East 29th Street
- 14 floor
- New York, NY 10016
- United States
OverT Bio Timeline
OverT Bio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Grant | 22-Nov-2024 | $120K | Completed | Clinical Trials - General | ||
3. Seed Round | 06-May-2024 | Completed | Clinical Trials - General | |||
2. Seed Round | $8M | $12.5M | Completed | Clinical Trials - General | ||
1. Seed Round | 04-Apr-2023 | $4.49M | $4.49M | Completed | Clinical Trials - General |
OverT Bio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed-2 | ||||||||
Seed-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
OverT Bio Comparisons
Industry
Financing
Details
OverT Bio Competitors (3)
One of OverT Bio’s 3 competitors is Longeveron, a Formerly VC-backed company based in Miami, FL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Longeveron | Formerly VC-backed | Miami, FL | ||||
Arcellx | Formerly VC-backed | Gaithersburg, MD | ||||
Chimeric Therapeutics | Formerly VC-backed | Carlton South, Australia |
OverT Bio Signals
OverT Bio Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
ScaleReady | Corporation | |||
Alexandria Venture Investments | Venture Capital | Minority | ||
ARTIS Ventures | Venture Capital | Minority | ||
Cancer Research Institute | Limited Partner | Minority | ||
Civilization Ventures | Venture Capital | Minority |
OverT Bio FAQs
-
When was OverT Bio founded?
OverT Bio was founded in 2022.
-
Where is OverT Bio headquartered?
OverT Bio is headquartered in New York, NY.
-
What is the size of OverT Bio?
OverT Bio has 10 total employees.
-
What industry is OverT Bio in?
OverT Bio’s primary industry is Drug Discovery.
-
Is OverT Bio a private or public company?
OverT Bio is a Private company.
-
What is OverT Bio’s current revenue?
The current revenue for OverT Bio is
. -
How much funding has OverT Bio raised over time?
OverT Bio has raised $28.5M.
-
Who are OverT Bio’s investors?
ScaleReady, Alexandria Venture Investments, ARTIS Ventures, Cancer Research Institute, and Civilization Ventures are 5 of 11 investors who have invested in OverT Bio.
-
Who are OverT Bio’s competitors?
Longeveron, Arcellx, and Chimeric Therapeutics are competitors of OverT Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »